BOM:524394 (India)
Â
Shs Dematerialised
₹
851.95
+7.85 (+0.91%)
Apr 9
What is a stock summary page? Click here for an overview.
Business Description
Vimta Labs Ltd
ISIN : INE579C01029
Share Class Description:
BOM:524394: Shs DematerialisedCompare
Compare
Traded in other countries / regions
524394.India IPO Date
1994-01-27Description
Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.59 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.11 | |||||
| Interest Coverage | 53.6 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 13.26 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.5 | |||||
| 3-Year EBITDA Growth Rate | 18.5 | |||||
| 3-Year EPS without NRI Growth Rate | 19 | |||||
| 3-Year Book Growth Rate | 17.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.88 | |||||
| 9-Day RSI | 35.95 | |||||
| 14-Day RSI | 40.44 | |||||
| 3-1 Month Momentum % | -4.53 | |||||
| 6-1 Month Momentum % | 79.09 | |||||
| 12-1 Month Momentum % | 98.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.22 | |||||
| Quick Ratio | 1.88 | |||||
| Cash Ratio | 0.39 | |||||
| Days Inventory | 102.44 | |||||
| Days Sales Outstanding | 89.02 | |||||
| Days Payable | 37.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.23 | |||||
| Dividend Payout Ratio | 0.08 | |||||
| Forward Dividend Yield % | 0.23 | |||||
| 5-Year Yield-on-Cost % | 0.23 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 0.32 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 75 | |||||
| Operating Margin % | 21.15 | |||||
| Net Margin % | 17.6 | |||||
| FCF Margin % | -4.37 | |||||
| ROE % | 19.75 | |||||
| ROA % | 15.56 | |||||
| ROIC % | 15.45 | |||||
| 3-Year ROIIC % | 16.03 | |||||
| ROC (Joel Greenblatt) % | 24.7 | |||||
| ROCE % | 21.48 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.21 | |||||
| Forward PE Ratio | 28.65 | |||||
| PE Ratio without NRI | 35.94 | |||||
| Shiller PE Ratio | 60.73 | |||||
| Price-to-Owner-Earnings | 57.39 | |||||
| PEG Ratio | 2 | |||||
| PS Ratio | 5.47 | |||||
| PB Ratio | 5.52 | |||||
| Price-to-Tangible-Book | 5.74 | |||||
| Price-to-Operating-Cash-Flow | 31.45 | |||||
| EV-to-EBIT | 25.47 | |||||
| EV-to-EBITDA | 17.23 | |||||
| EV-to-Revenue | 5.23 | |||||
| EV-to-FCF | -119.64 | |||||
| Price-to-GF-Value | 1.53 | |||||
| Price-to-DCF (Earnings Based) | 1.38 | |||||
| Price-to-Median-PS-Value | 2.43 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.44 | |||||
| Earnings Yield (Greenblatt) % | 3.93 | |||||
| FCF Yield % | -0.83 | |||||
| Forward Rate of Return (Yacktman) % | 20 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vimta Labs Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,588.19 | ||
| EPS (TTM) (₹) | 27.3 | ||
| Beta | 0.41 | ||
| 3-Year Sharpe Ratio | 0.81 | ||
| 3-Year Sortino Ratio | 1.72 | ||
| Volatility % | 74.72 | ||
| 14-Day RSI | 40.44 | ||
| 14-Day ATR (₹) | 86.946232 | ||
| 20-Day SMA (₹) | 1025.06 | ||
| 12-1 Month Momentum % | 98.85 | ||
| 52-Week Range (₹) | 420 - 1183 | ||
| Shares Outstanding (Mil) | 22.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vimta Labs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vimta Labs Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vimta Labs Ltd Frequently Asked Questions
What is Vimta Labs Ltd(BOM:524394)'s stock price today?
The current price of BOM:524394 is ₹851.95. The 52 week high of BOM:524394 is ₹1183.00 and 52 week low is ₹420.00.
When is next earnings date of Vimta Labs Ltd(BOM:524394)?
The next earnings date of Vimta Labs Ltd(BOM:524394) is .
Does Vimta Labs Ltd(BOM:524394) pay dividends? If so, how much?
The Dividend Yield %  of Vimta Labs Ltd(BOM:524394) is 0.23% (As of Today), Highest Dividend Payout Ratio of Vimta Labs Ltd(BOM:524394) was 0.72. The lowest was 0.08. And the median was 0.17. The  Forward Dividend Yield % of Vimta Labs Ltd(BOM:524394) is 0.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers